# Characterizing Guideline Adoption and Treatment Quality in Clinical Routine of German HFrEF Care

> **NCT06004453** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 899 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **OTHER:** Heart Failure medications

## Key facts

- **NCT ID:** NCT06004453
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-03
- **Primary completion:** 2025-01-17
- **Final completion:** 2025-01-17
- **Target enrollment:** 899 (ACTUAL)
- **Last updated:** 2025-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06004453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06004453, "Characterizing Guideline Adoption and Treatment Quality in Clinical Routine of German HFrEF Care". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06004453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*